TITLE

Application of custom-designed oligonucleotide array CGH in 145 patients with autistic spectrum disorders

AUTHOR(S)
Wiśniowiecka-Kowalnik, Barbara; Kastory-Bronowska, Monika; Bartnik, Magdalena; Derwińska, Katarzyna; Dymczak-Domini, Wanda; Szumbarska, Dorota; Ziemka, Ewa; Szczałuba, Krzysztof; Sykulski, Maciej; Gambin, Tomasz; Gambin, Anna; Shaw, Chad A; Mazurczak, Tadeusz; Obersztyn, Ewa; Bocian, Ewa; Stankiewicz, Paweł
PUB. DATE
June 2013
SOURCE
European Journal of Human Genetics;Jun2013, Vol. 21 Issue 6, p620
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Autism spectrum disorders (ASDs) are a heterogeneous group of neurodevelopmental disorders, including childhood autism, atypical autism, and Asperger syndrome, with an estimated prevalence of 1.0-2.5% in the general population. ASDs have a complex multifactorial etiology, with genetic causes being recognized in only 10-20% of cases. Recently, copy-number variants (CNVs) have been shown to contribute to over 10% of ASD cases. We have applied a custom-designed oligonucleotide array comparative genomic hybridization with an exonic coverage of over 1700 genes, including 221 genes known to cause autism and autism candidate genes, in a cohort of 145 patients with ASDs. The patients were classified according to ICD-10 standards and the Childhood Autism Rating Scale protocol into three groups consisting of 45 individuals with and 69 individuals without developmental delay/intellectual disability (DD/ID), and 31 patients, in whom DD/ID could not be excluded. In 12 patients, we have identified 16 copy-number changes, eight (5.5%) of which likely contribute to ASDs. In addition to known recurrent CNVs such as deletions 15q11.2 (BP1-BP2) and 3q13.31 (including DRD3 and ZBTB20), and duplications 15q13.3 and 16p13.11, our analysis revealed two novel genes clinically relevant for ASDs: ARHGAP24 (4q21.23q21.3) and SLC16A7 (12q14.1). Our results further confirm the diagnostic importance of array CGH in detection of CNVs in patients with ASDs and demonstrate that CNVs are an important cause of ASDs as a heterogeneous condition with a variety of contributory genes.
ACCESSION #
87598072

 

Related Articles

  • Genetic Anticipation and Autism. RAI, BIRENDRA; SHARIF, FARHANA // Indian Pediatrics;Oct2014, Vol. 51 Issue 10, p841 

    The article discusses the case of a boy who was diagnosed with autistic spectrum disorder (ASD). Topics discussed include a delay in the patient's fine motor, personal social and communication skills, genomic hybridization which revealed a microdeletion from chromosome 7q33, and important genes...

  • Pathogenic copy number variants (pCNVs) in individuals diagnosed on the autism spectrum disorder (ASD): A closer look at candidate genes. Baniaga, Allan Dale // McGill Science Undergraduate Research Journal;2011, Vol. 6 Issue 1, p15 

    Introduction: The genetic basis for autism spectrum disorders (ASDs) is well established and its heterogenetic nature provides us with substantial evidence for the many chromosomal aberrations associated with this complex disorder (5). However, little is known about the genes that occupy the...

  • Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders.  // Molecular Cytogenetics (17558166);2012, Vol. 5 Issue 1, p17 

    The article presents a study investigating the association of deletions in chromosome 6p22.3-p24.3, including ATXN1 gene with developmental delay and autism spectrum disorders (ASDs). As mentioned, using array comparative genomic hybridization (CGH) to search for copy-number variants (CNVs) that...

  • Pharmacogenomic Medicine in Autism: Challenges and Opportunities. Bowers, Katherine; Lin, Ping-I; Erickson, Craig // Pediatric Drugs;Apr2015, Vol. 17 Issue 2, p115 

    Autism spectrum disorder (ASD) affects 1 in 68 children in the US and is distinguished by core deficits in social interactions. Developing pharmacologic treatments for ASD is complicated by clinical and genetic heterogeneity. Although pharmacological treatments have not been shown to be...

  • Autism: The importance of getting the dose right. Welberg, Leonie // Nature Reviews Neuroscience;Aug2011, Vol. 12 Issue 8, p429 

    The article discusses research being done on gene dosage in autism spectrum disorders (ASD). It references several studies including "Rare de novo and transmitted copy-number variation in autistic spectrum disorders" by D. Levy and colleagues in the 2011 issue. Moreover, it states that the...

  • Common genetic variants, acting additively, are a major source of risk for autism. Klei, Lambertus; Sanders, Stephan J.; Murtha, Michael T.; Hus, Vanessa; Lowe, Jennifer K.; Jeremy Willsey, A.; Moreno-De-Luca, Daniel; Yu, Timothy W.; Fombonne, Eric; Geschwind, Daniel; Grice, Dorothy E.; Ledbetter, David H.; Lord, Catherine; Mane, Shrikant M.; Martin, Christa Lese; Martin, Donna M.; Morrow, Eric M.; Walsh, Christopher A.; Melhem, Nadine M.; Chaste, Pauline // Molecular Autism;2012, Vol. 3 Issue 1, p1 

    Background: Autism spectrum disorders (ASD) are early onset neurodevelopmental syndromes typified by impairments in reciprocal social interaction and communication, accompanied by restricted and repetitive behaviors. While rare and especially de novo genetic variation are known to affect...

  • Gene-Network Analysis Identifies Susceptibility Genes Related to Glycobiology in Autism. van der Zwaag, Bert; Franke, Lude; Poot, Martin; Hochstenbach, Ron; Spierenburg, Henk A.; Vorstman, Jacob A. S.; van Daalen, Emma; de Jonge, Maretha V.; Verbeek, Nienke E.; Brilstra, Eva H.; van 't Slot, Ruben; Ophoff, Roel A.; van Es, Michael A.; Blauw, Hylke M.; Veldink, Jan H.; Buizer-Voskamp, Jacobine E.; Beemer, Frits A.; van den Berg, Leonard H.; Wijmenga, Cisca; van Amstel, Hans Kristian Ploos // PLoS ONE;2009, Vol. 4 Issue 5, p1 

    The recent identification of copy-number variation in the human genome has opened up new avenues for the discovery of positional candidate genes underlying complex genetic disorders, especially in the field of psychiatric disease. One major challenge that remains is pinpointing the...

  • Autism Speaks and BGI to complete whole genome sequencing on 10,000 with autism.  // Biomedical Market Newsletter;10/17/2011, Vol. 21, p595 

    The article reports on the partnership of the Autism Speaks Genetic with Beijing Genomics Institute (BGI) for the completion of genome sequencing on children with autism spectrum.

  • Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA. López, Virginia; González-Peramato, Pilar; Suela, Javier; Serrano, Alvaro; Algaba, Ferrán; Cigudosa, Juan C.; Vidal, August; Bellmunt, Joaquim; Heredero, Oscar; Sánchez-Carbayo, Marta // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background: Array-CGH represents a comprehensive tool to discover genomic disease alterations that could potentially be applied to body fluids. In this report, we aimed at applying array-CGH to urinary samples to characterize bladder cancer. Methods: Urinary DNA from bladder cancer patients and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics